Christopher G. Hayes, Chief Legal Officer at Verrica Pharmaceuticals Inc. (VRCA), bought 5,714 shares at $2.10 ($12K) on 2022-07-05, disclosed to the SEC on 2022-07-05.
Open-market purchase of $12k VRCA by Chief Legal Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Clearly above the average filing.
| Filing → |
| VRCA | SELL | 2024-07-23 | $306K | — | Filing → |
| VRCA | SELL | 2023-11-16 | $164K | — | Filing → |
| VRCA | SELL | 2023-07-25 | $326K | — | Filing → |